PDB Short entry for 5EAK HEADER TRANSFERASE/TRANSFERASE INHIBITOR 16-OCT-15 5EAK TITLE OPTIMIZATION OF MICROTUBULE AFFINITY REGULATING KINASE (MARK) TITLE 2 INHIBITORS WITH IMPROVED PHYSICAL PROPERTIES COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE MARK2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN (UNP RESIDUES 39-364); COMPND 5 SYNONYM: ELKL MOTIF KINASE 1,EMK-1,MAP/MICROTUBULE AFFINITY- COMPND 6 REGULATING KINASE 2,PAR1 HOMOLOG,PAR1 HOMOLOG B,PAR1B; COMPND 7 EC: 2.7.11.1,2.7.11.26; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MARK2, EMK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS CATALYTIC DOMAIN, PROTEIN-SERINE-THREONINE KINASES, KINASE INHIBITOR, KEYWDS 2 SERINE-THREONINE KINASES, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.P.SU REVDAT 4 06-MAR-24 5EAK 1 REMARK REVDAT 3 22-NOV-17 5EAK 1 JRNL REMARK REVDAT 2 24-AUG-16 5EAK 1 JRNL REVDAT 1 17-FEB-16 5EAK 0 JRNL AUTH D.L.SLOMAN,N.NOUCTI,M.D.ALTMAN,D.CHEN,A.C.MISLAK,A.SZEWCZAK, JRNL AUTH 2 M.HAYASHI,L.WARREN,T.DELLOVADE,Z.WU,J.MARCUS,D.WALKER, JRNL AUTH 3 H.P.SU,S.C.EDAVETTAL,S.MUNSHI,M.HUTTON,H.NUTHALL,M.G.STANTON JRNL TITL OPTIMIZATION OF MICROTUBULE AFFINITY REGULATING KINASE JRNL TITL 2 (MARK) INHIBITORS WITH IMPROVED PHYSICAL PROPERTIES. JRNL REF BIOORG.MED.CHEM.LETT. V. 26 4362 2016 JRNL REFN ESSN 1464-3405 JRNL PMID 27491711 JRNL DOI 10.1016/J.BMCL.2016.02.003 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.6.4_486 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.68 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 21064 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.150 REMARK 3 FREE R VALUE TEST SET COUNT : 1084 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.6864 - 5.5872 1.00 2563 127 0.1959 0.2391 REMARK 3 2 5.5872 - 4.4395 1.00 2507 129 0.1673 0.1923 REMARK 3 3 4.4395 - 3.8797 1.00 2505 130 0.1719 0.2351 REMARK 3 4 3.8797 - 3.5256 1.00 2469 162 0.1756 0.2434 REMARK 3 5 3.5256 - 3.2732 1.00 2488 128 0.1928 0.2375 REMARK 3 6 3.2732 - 3.0805 1.00 2502 133 0.2141 0.3233 REMARK 3 7 3.0805 - 2.9263 1.00 2481 149 0.2566 0.3368 REMARK 3 8 2.9263 - 2.7990 1.00 2465 126 0.2899 0.3677 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.83 REMARK 3 K_SOL : 0.35 REMARK 3 B_SOL : 16.78 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.420 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.890 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.29 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.43280 REMARK 3 B22 (A**2) : -0.43280 REMARK 3 B33 (A**2) : 0.86550 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 5081 REMARK 3 ANGLE : 1.218 6844 REMARK 3 CHIRALITY : 0.079 738 REMARK 3 PLANARITY : 0.004 866 REMARK 3 DIHEDRAL : 16.683 1933 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5EAK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-OCT-15. REMARK 100 THE DEPOSITION ID IS D_1000214600. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-JUL-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000, DENZO REMARK 200 DATA SCALING SOFTWARE : HKL-2000, SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21123 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 9.600 REMARK 200 R MERGE (I) : 0.10400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 9.60 REMARK 200 R MERGE FOR SHELL (I) : 0.44200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.09 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.87 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M BIS-TRIS PH 6.5, 14% PEG3350, REMARK 280 200MM AMM.SULFATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 35.53067 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 71.06133 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 53.29600 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 88.82667 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 17.76533 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 37 REMARK 465 LEU A 38 REMARK 465 ASN A 39 REMARK 465 SER A 40 REMARK 465 ALA A 41 REMARK 465 THR A 42 REMARK 465 SER A 43 REMARK 465 ALA A 44 REMARK 465 ASP A 45 REMARK 465 GLU A 46 REMARK 465 ASN A 198 REMARK 465 GLU A 199 REMARK 465 PHE A 200 REMARK 465 THR A 201 REMARK 465 PHE A 202 REMARK 465 GLY A 203 REMARK 465 ASN A 204 REMARK 465 LYS A 205 REMARK 465 LEU A 206 REMARK 465 ASP A 207 REMARK 465 THR A 208 REMARK 465 TYR A 363 REMARK 465 LYS A 364 REMARK 465 LYS B 37 REMARK 465 LEU B 38 REMARK 465 ASN B 39 REMARK 465 SER B 40 REMARK 465 ALA B 41 REMARK 465 THR B 42 REMARK 465 SER B 43 REMARK 465 ALA B 44 REMARK 465 ASP B 45 REMARK 465 GLU B 46 REMARK 465 GLN B 47 REMARK 465 PRO B 48 REMARK 465 HIS B 49 REMARK 465 ILE B 50 REMARK 465 SER B 197 REMARK 465 ASN B 198 REMARK 465 GLU B 199 REMARK 465 PHE B 200 REMARK 465 THR B 201 REMARK 465 PHE B 202 REMARK 465 GLY B 203 REMARK 465 ASN B 204 REMARK 465 LYS B 205 REMARK 465 LEU B 206 REMARK 465 ASP B 207 REMARK 465 THR B 208 REMARK 465 PHE B 209 REMARK 465 LYS B 364 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 57 127.72 -172.40 REMARK 500 ARG A 174 -11.10 75.05 REMARK 500 ASP A 175 36.49 -140.74 REMARK 500 ASP A 193 96.61 77.77 REMARK 500 PHE A 196 71.94 38.92 REMARK 500 ASP A 311 35.81 -169.24 REMARK 500 GLU A 312 152.15 -47.01 REMARK 500 ASP A 325 109.77 -59.60 REMARK 500 LEU A 361 47.18 -79.76 REMARK 500 LEU B 56 -64.40 -102.15 REMARK 500 ASN B 63 -75.93 -39.97 REMARK 500 THR B 121 -168.19 -122.47 REMARK 500 ASP B 175 33.18 -149.21 REMARK 500 MET B 187 14.57 81.45 REMARK 500 LYS B 225 157.42 -48.16 REMARK 500 ASP B 311 53.58 -169.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 24R A 1000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 24R B 1000 DBREF 5EAK A 39 364 UNP Q7KZI7 MARK2_HUMAN 39 364 DBREF 5EAK B 39 364 UNP Q7KZI7 MARK2_HUMAN 39 364 SEQADV 5EAK LYS A 37 UNP Q7KZI7 EXPRESSION TAG SEQADV 5EAK LEU A 38 UNP Q7KZI7 EXPRESSION TAG SEQADV 5EAK LYS B 37 UNP Q7KZI7 EXPRESSION TAG SEQADV 5EAK LEU B 38 UNP Q7KZI7 EXPRESSION TAG SEQRES 1 A 328 LYS LEU ASN SER ALA THR SER ALA ASP GLU GLN PRO HIS SEQRES 2 A 328 ILE GLY ASN TYR ARG LEU LEU LYS THR ILE GLY LYS GLY SEQRES 3 A 328 ASN PHE ALA LYS VAL LYS LEU ALA ARG HIS ILE LEU THR SEQRES 4 A 328 GLY LYS GLU VAL ALA VAL LYS ILE ILE ASP LYS THR GLN SEQRES 5 A 328 LEU ASN SER SER SER LEU GLN LYS LEU PHE ARG GLU VAL SEQRES 6 A 328 ARG ILE MET LYS VAL LEU ASN HIS PRO ASN ILE VAL LYS SEQRES 7 A 328 LEU PHE GLU VAL ILE GLU THR GLU LYS THR LEU TYR LEU SEQRES 8 A 328 VAL MET GLU TYR ALA SER GLY GLY GLU VAL PHE ASP TYR SEQRES 9 A 328 LEU VAL ALA HIS GLY ARG MET LYS GLU LYS GLU ALA ARG SEQRES 10 A 328 ALA LYS PHE ARG GLN ILE VAL SER ALA VAL GLN TYR CYS SEQRES 11 A 328 HIS GLN LYS PHE ILE VAL HIS ARG ASP LEU LYS ALA GLU SEQRES 12 A 328 ASN LEU LEU LEU ASP ALA ASP MET ASN ILE LYS ILE ALA SEQRES 13 A 328 ASP PHE GLY PHE SER ASN GLU PHE THR PHE GLY ASN LYS SEQRES 14 A 328 LEU ASP THR PHE CYS GLY SER PRO PRO TYR ALA ALA PRO SEQRES 15 A 328 GLU LEU PHE GLN GLY LYS LYS TYR ASP GLY PRO GLU VAL SEQRES 16 A 328 ASP VAL TRP SER LEU GLY VAL ILE LEU TYR THR LEU VAL SEQRES 17 A 328 SER GLY SER LEU PRO PHE ASP GLY GLN ASN LEU LYS GLU SEQRES 18 A 328 LEU ARG GLU ARG VAL LEU ARG GLY LYS TYR ARG ILE PRO SEQRES 19 A 328 PHE TYR MET SER THR ASP CYS GLU ASN LEU LEU LYS LYS SEQRES 20 A 328 PHE LEU ILE LEU ASN PRO SER LYS ARG GLY THR LEU GLU SEQRES 21 A 328 GLN ILE MET LYS ASP ARG TRP MET ASN VAL GLY HIS GLU SEQRES 22 A 328 ASP ASP GLU LEU LYS PRO TYR VAL GLU PRO LEU PRO ASP SEQRES 23 A 328 TYR LYS ASP PRO ARG ARG THR GLU LEU MET VAL SER MET SEQRES 24 A 328 GLY TYR THR ARG GLU GLU ILE GLN ASP SER LEU VAL GLY SEQRES 25 A 328 GLN ARG TYR ASN GLU VAL MET ALA THR TYR LEU LEU LEU SEQRES 26 A 328 GLY TYR LYS SEQRES 1 B 328 LYS LEU ASN SER ALA THR SER ALA ASP GLU GLN PRO HIS SEQRES 2 B 328 ILE GLY ASN TYR ARG LEU LEU LYS THR ILE GLY LYS GLY SEQRES 3 B 328 ASN PHE ALA LYS VAL LYS LEU ALA ARG HIS ILE LEU THR SEQRES 4 B 328 GLY LYS GLU VAL ALA VAL LYS ILE ILE ASP LYS THR GLN SEQRES 5 B 328 LEU ASN SER SER SER LEU GLN LYS LEU PHE ARG GLU VAL SEQRES 6 B 328 ARG ILE MET LYS VAL LEU ASN HIS PRO ASN ILE VAL LYS SEQRES 7 B 328 LEU PHE GLU VAL ILE GLU THR GLU LYS THR LEU TYR LEU SEQRES 8 B 328 VAL MET GLU TYR ALA SER GLY GLY GLU VAL PHE ASP TYR SEQRES 9 B 328 LEU VAL ALA HIS GLY ARG MET LYS GLU LYS GLU ALA ARG SEQRES 10 B 328 ALA LYS PHE ARG GLN ILE VAL SER ALA VAL GLN TYR CYS SEQRES 11 B 328 HIS GLN LYS PHE ILE VAL HIS ARG ASP LEU LYS ALA GLU SEQRES 12 B 328 ASN LEU LEU LEU ASP ALA ASP MET ASN ILE LYS ILE ALA SEQRES 13 B 328 ASP PHE GLY PHE SER ASN GLU PHE THR PHE GLY ASN LYS SEQRES 14 B 328 LEU ASP THR PHE CYS GLY SER PRO PRO TYR ALA ALA PRO SEQRES 15 B 328 GLU LEU PHE GLN GLY LYS LYS TYR ASP GLY PRO GLU VAL SEQRES 16 B 328 ASP VAL TRP SER LEU GLY VAL ILE LEU TYR THR LEU VAL SEQRES 17 B 328 SER GLY SER LEU PRO PHE ASP GLY GLN ASN LEU LYS GLU SEQRES 18 B 328 LEU ARG GLU ARG VAL LEU ARG GLY LYS TYR ARG ILE PRO SEQRES 19 B 328 PHE TYR MET SER THR ASP CYS GLU ASN LEU LEU LYS LYS SEQRES 20 B 328 PHE LEU ILE LEU ASN PRO SER LYS ARG GLY THR LEU GLU SEQRES 21 B 328 GLN ILE MET LYS ASP ARG TRP MET ASN VAL GLY HIS GLU SEQRES 22 B 328 ASP ASP GLU LEU LYS PRO TYR VAL GLU PRO LEU PRO ASP SEQRES 23 B 328 TYR LYS ASP PRO ARG ARG THR GLU LEU MET VAL SER MET SEQRES 24 B 328 GLY TYR THR ARG GLU GLU ILE GLN ASP SER LEU VAL GLY SEQRES 25 B 328 GLN ARG TYR ASN GLU VAL MET ALA THR TYR LEU LEU LEU SEQRES 26 B 328 GLY TYR LYS HET 24R A1000 30 HET 24R B1000 30 HETNAM 24R N-[(1S,2R)-2-AMINOCYCLOHEXYL]-4-[6-(1-METHYL-1H- HETNAM 2 24R PYRAZOL-4-YL)PYRAZOLO[1,5-A]PYRIMIDIN-3-YL]THIOPHENE- HETNAM 3 24R 2-CARBOXAMIDE FORMUL 3 24R 2(C21 H23 N7 O S) FORMUL 5 HOH *6(H2 O) HELIX 1 AA1 THR A 87 LEU A 89 5 3 HELIX 2 AA2 ASN A 90 LEU A 107 1 18 HELIX 3 AA3 VAL A 137 GLY A 145 1 9 HELIX 4 AA4 LYS A 148 LYS A 169 1 22 HELIX 5 AA5 LYS A 177 GLU A 179 5 3 HELIX 6 AA6 SER A 212 ALA A 216 5 5 HELIX 7 AA7 ALA A 217 GLY A 223 5 7 HELIX 8 AA8 GLY A 228 GLY A 246 1 19 HELIX 9 AA9 ASN A 254 GLY A 265 1 12 HELIX 10 AB1 SER A 274 LEU A 285 1 12 HELIX 11 AB2 ASN A 288 ARG A 292 5 5 HELIX 12 AB3 THR A 294 MET A 299 1 6 HELIX 13 AB4 ASP A 301 VAL A 306 1 6 HELIX 14 AB5 ASP A 325 SER A 334 1 10 HELIX 15 AB6 THR A 338 GLY A 348 1 11 HELIX 16 AB7 ASN A 352 LEU A 361 1 10 HELIX 17 AB8 THR B 87 LEU B 89 5 3 HELIX 18 AB9 ASN B 90 LEU B 107 1 18 HELIX 19 AC1 VAL B 137 GLY B 145 1 9 HELIX 20 AC2 LYS B 148 LYS B 169 1 22 HELIX 21 AC3 LYS B 177 GLU B 179 5 3 HELIX 22 AC4 SER B 212 ALA B 216 5 5 HELIX 23 AC5 ALA B 217 GLY B 223 5 7 HELIX 24 AC6 GLY B 228 GLY B 246 1 19 HELIX 25 AC7 ASN B 254 GLY B 265 1 12 HELIX 26 AC8 SER B 274 LEU B 285 1 12 HELIX 27 AC9 ASN B 288 ARG B 292 5 5 HELIX 28 AD1 THR B 294 MET B 299 1 6 HELIX 29 AD2 ASP B 301 VAL B 306 1 6 HELIX 30 AD3 ASP B 325 SER B 334 1 10 HELIX 31 AD4 THR B 338 GLY B 348 1 11 HELIX 32 AD5 ASN B 352 LEU B 361 1 10 SHEET 1 AA1 5 TYR A 53 LYS A 61 0 SHEET 2 AA1 5 ALA A 65 HIS A 72 -1 O LEU A 69 N LYS A 57 SHEET 3 AA1 5 GLU A 78 ASP A 85 -1 O VAL A 81 N LYS A 68 SHEET 4 AA1 5 THR A 124 GLU A 130 -1 O MET A 129 N ALA A 80 SHEET 5 AA1 5 LEU A 115 GLU A 120 -1 N PHE A 116 O VAL A 128 SHEET 1 AA2 3 GLY A 135 GLU A 136 0 SHEET 2 AA2 3 LEU A 181 LEU A 183 -1 O LEU A 183 N GLY A 135 SHEET 3 AA2 3 ILE A 189 ILE A 191 -1 O LYS A 190 N LEU A 182 SHEET 1 AA3 5 TYR B 53 LYS B 61 0 SHEET 2 AA3 5 ALA B 65 HIS B 72 -1 O VAL B 67 N GLY B 60 SHEET 3 AA3 5 GLU B 78 ASP B 85 -1 O ILE B 83 N LYS B 66 SHEET 4 AA3 5 THR B 124 MET B 129 -1 O MET B 129 N ALA B 80 SHEET 5 AA3 5 LEU B 115 GLU B 120 -1 N PHE B 116 O VAL B 128 SHEET 1 AA4 3 GLY B 135 GLU B 136 0 SHEET 2 AA4 3 LEU B 181 LEU B 183 -1 O LEU B 183 N GLY B 135 SHEET 3 AA4 3 ILE B 189 ILE B 191 -1 O LYS B 190 N LEU B 182 SITE 1 AC1 15 GLY A 60 LYS A 61 VAL A 67 ALA A 80 SITE 2 AC1 15 LYS A 82 MET A 129 GLU A 130 TYR A 131 SITE 3 AC1 15 ALA A 132 SER A 133 GLY A 135 GLU A 179 SITE 4 AC1 15 LEU A 182 ASP A 193 SER A 197 SITE 1 AC2 11 LYS B 61 ALA B 80 LYS B 82 MET B 129 SITE 2 AC2 11 GLU B 130 TYR B 131 ALA B 132 SER B 133 SITE 3 AC2 11 GLU B 179 LEU B 182 ASP B 193 CRYST1 118.739 118.739 106.592 90.00 90.00 120.00 P 61 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008422 0.004862 0.000000 0.00000 SCALE2 0.000000 0.009725 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009382 0.00000